

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.41648061 |
| 2 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.40231475 |
| 3 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.28120035 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.28120035 |
| 5 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.20138559 |
| 6 | positive regulation of cellular amide metabolic process (GO:0034250) | 4.09133990 |
| 7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.97548797 |
| 8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.97548797 |
| 9 | modulation by symbiont of host immune response (GO:0052553) | 3.97548797 |
| 10 | positive regulation by symbiont of host defense response (GO:0052509) | 3.97548797 |
| 11 | modulation by symbiont of host defense response (GO:0052031) | 3.97548797 |
| 12 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.97548797 |
| 13 | positive regulation of granulocyte differentiation (GO:0030854) | 3.94565621 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 3.90078904 |
| 15 | neutrophil activation involved in immune response (GO:0002283) | 3.81344917 |
| 16 | positive regulation of histone H3-K4 methylation (GO:0051571) | 3.76298567 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76124622 |
| 18 | response to peptidoglycan (GO:0032494) | 3.71363292 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 3.69530702 |
| 20 | response to muramyl dipeptide (GO:0032495) | 3.68752541 |
| 21 | NIK/NF-kappaB signaling (GO:0038061) | 3.63461328 |
| 22 | response to type I interferon (GO:0034340) | 3.63325197 |
| 23 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.59483698 |
| 24 | cellular response to type I interferon (GO:0071357) | 3.59261178 |
| 25 | type I interferon signaling pathway (GO:0060337) | 3.59261178 |
| 26 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 3.57114350 |
| 27 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 3.57114350 |
| 28 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 3.57114350 |
| 29 | regulation of histone H3-K27 methylation (GO:0061085) | 3.55550999 |
| 30 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.53716421 |
| 31 | peptidyl-lysine trimethylation (GO:0018023) | 3.49215278 |
| 32 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.45090193 |
| 33 | positive regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033141) | 3.37454021 |
| 34 | regulation of peptidyl-serine phosphorylation of STAT protein (GO:0033139) | 3.37454021 |
| 35 | neutrophil activation (GO:0042119) | 3.36877109 |
| 36 | positive regulation of B cell differentiation (GO:0045579) | 3.36699901 |
| 37 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.34619405 |
| 38 | regulation of RNA export from nucleus (GO:0046831) | 3.34414247 |
| 39 | T cell migration (GO:0072678) | 3.30437821 |
| 40 | regulation of RIG-I signaling pathway (GO:0039535) | 3.30398029 |
| 41 | mRNA modification (GO:0016556) | 3.30105234 |
| 42 | regulation of fibroblast apoptotic process (GO:2000269) | 3.25827218 |
| 43 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.23689547 |
| 44 | histone H3-K4 methylation (GO:0051568) | 3.21646691 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.19515631 |
| 46 | positive T cell selection (GO:0043368) | 3.19345858 |
| 47 | cellular response to ethanol (GO:0071361) | 3.17589564 |
| 48 | mitotic sister chromatid cohesion (GO:0007064) | 3.17443936 |
| 49 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.14735546 |
| 50 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.11992464 |
| 51 | granulocyte activation (GO:0036230) | 3.11533086 |
| 52 | regulation of histone H3-K4 methylation (GO:0051569) | 3.08886282 |
| 53 | germinal center formation (GO:0002467) | 3.08458763 |
| 54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.08359407 |
| 55 | response to interferon-alpha (GO:0035455) | 3.07957878 |
| 56 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.04874540 |
| 57 | macrophage activation involved in immune response (GO:0002281) | 3.04302490 |
| 58 | regulation of B cell differentiation (GO:0045577) | 3.00967465 |
| 59 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.99759286 |
| 60 | regulation of MHC class I biosynthetic process (GO:0045343) | 2.99483102 |
| 61 | interferon-gamma production (GO:0032609) | 2.98039057 |
| 62 | positive regulation of interferon-beta production (GO:0032728) | 2.97848922 |
| 63 | neutrophil mediated immunity (GO:0002446) | 2.97034398 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.96306197 |
| 65 | positive thymic T cell selection (GO:0045059) | 2.95220195 |
| 66 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.93797329 |
| 67 | defense response to protozoan (GO:0042832) | 2.93676496 |
| 68 | I-kappaB phosphorylation (GO:0007252) | 2.93434210 |
| 69 | COPII vesicle coating (GO:0048208) | 2.92019585 |
| 70 | immunoglobulin mediated immune response (GO:0016064) | 2.91622699 |
| 71 | histone H3-K4 trimethylation (GO:0080182) | 2.89469443 |
| 72 | leukocyte aggregation (GO:0070486) | 2.87991494 |
| 73 | positive regulation of interleukin-12 production (GO:0032735) | 2.87930241 |
| 74 | negative thymic T cell selection (GO:0045060) | 2.87646848 |
| 75 | B cell homeostasis (GO:0001782) | 2.87003943 |
| 76 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.86950263 |
| 77 | B cell receptor signaling pathway (GO:0050853) | 2.86912732 |
| 78 | response to host immune response (GO:0052572) | 2.86899472 |
| 79 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.86899472 |
| 80 | T-helper 1 type immune response (GO:0042088) | 2.85062107 |
| 81 | T cell homeostasis (GO:0043029) | 2.84651811 |
| 82 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.83754586 |
| 83 | negative T cell selection (GO:0043383) | 2.83640903 |
| 84 | mature B cell differentiation (GO:0002335) | 2.83399883 |
| 85 | necrotic cell death (GO:0070265) | 2.80358889 |
| 86 | negative regulation of bone resorption (GO:0045779) | 2.78306077 |
| 87 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.78100682 |
| 88 | regulation of antigen processing and presentation (GO:0002577) | 2.77939397 |
| 89 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.77872593 |
| 90 | response to protozoan (GO:0001562) | 2.76400449 |
| 91 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.75235529 |
| 92 | monoubiquitinated protein deubiquitination (GO:0035520) | 2.74983821 |
| 93 | peptidyl-lysine methylation (GO:0018022) | 2.74873893 |
| 94 | nuclear pore complex assembly (GO:0051292) | 2.74349146 |
| 95 | cellular response to interferon-beta (GO:0035458) | 2.73966773 |
| 96 | detection of other organism (GO:0098543) | 2.73759793 |
| 97 | myeloid cell activation involved in immune response (GO:0002275) | 2.72933385 |
| 98 | positive regulation of interleukin-2 production (GO:0032743) | 2.72391673 |
| 99 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.72227824 |
| 100 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.71804321 |
| 101 | natural killer cell mediated immunity (GO:0002228) | 2.71804321 |
| 102 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 2.70268251 |
| 103 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.69956093 |
| 104 | myeloid dendritic cell activation (GO:0001773) | 2.69844618 |
| 105 | programmed necrotic cell death (GO:0097300) | 2.65517695 |
| 106 | cellular response to exogenous dsRNA (GO:0071360) | 2.63597712 |
| 107 | T-helper cell differentiation (GO:0042093) | 2.63417485 |
| 108 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.63417485 |
| 109 | necroptotic process (GO:0070266) | 2.63215901 |
| 110 | response to host (GO:0075136) | 2.62915399 |
| 111 | response to host defenses (GO:0052200) | 2.62915399 |
| 112 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.62915399 |
| 113 | histone H3-K9 demethylation (GO:0033169) | 2.62825525 |
| 114 | histone mRNA catabolic process (GO:0071044) | 2.62317395 |
| 115 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.62247495 |
| 116 | definitive hemopoiesis (GO:0060216) | 2.60735751 |
| 117 | B cell proliferation (GO:0042100) | 2.59373847 |
| 118 | detection of molecule of bacterial origin (GO:0032490) | 2.58700351 |
| 119 | mitochondrial DNA replication (GO:0006264) | 2.57756774 |
| 120 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.57380988 |
| 121 | histone H4-K16 acetylation (GO:0043984) | 2.57380326 |
| 122 | cytoplasmic pattern recognition receptor signaling pathway (GO:0002753) | 2.57257821 |
| 123 | respiratory burst (GO:0045730) | 2.56616280 |
| 124 | regulation of necroptotic process (GO:0060544) | 2.55689434 |
| 125 | negative regulation of histone methylation (GO:0031061) | 2.55244892 |
| 126 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.55120167 |
| 127 | T cell selection (GO:0045058) | 2.55066256 |
| 128 | JAK-STAT cascade (GO:0007259) | 2.54947435 |
| 129 | negative regulation of B cell proliferation (GO:0030889) | 2.54793408 |
| 130 | cellular extravasation (GO:0045123) | 2.54601775 |
| 131 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.54226848 |
| 132 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.54061737 |
| 133 | negative regulation of interleukin-12 production (GO:0032695) | 2.54039279 |
| 134 | regulation of interleukin-12 production (GO:0032655) | 2.53054815 |
| 135 | negative regulation of viral genome replication (GO:0045071) | 2.52928063 |
| 136 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.52809582 |
| 137 | positive regulation of response to biotic stimulus (GO:0002833) | 2.52540629 |
| 138 | detection of bacterium (GO:0016045) | 2.52430725 |
| 139 | response to interleukin-15 (GO:0070672) | 2.52114298 |
| 140 | positive regulation of interleukin-17 production (GO:0032740) | 2.52038577 |
| 141 | cytokine secretion (GO:0050663) | 2.51223574 |
| 142 | histone H2A acetylation (GO:0043968) | 2.50615051 |
| 143 | negative regulation of bone remodeling (GO:0046851) | 2.48767910 |
| 144 | regulation of regulatory T cell differentiation (GO:0045589) | 2.47345026 |
| 145 | tolerance induction (GO:0002507) | 2.46642079 |
| 146 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.46430473 |
| 147 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.46337942 |
| 148 | regulation of response to interferon-gamma (GO:0060330) | 2.45813307 |
| 149 | histone H3-K36 demethylation (GO:0070544) | 2.45622465 |
| 150 | lymphocyte homeostasis (GO:0002260) | 2.43955405 |
| 151 | negative regulation of mRNA processing (GO:0050686) | 2.43101237 |
| 152 | nuclear pore organization (GO:0006999) | 2.42592074 |
| 153 | T cell lineage commitment (GO:0002360) | 2.41567336 |
| 154 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.41058302 |
| 155 | histone H2A ubiquitination (GO:0033522) | 2.39584687 |
| 156 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.38277534 |
| 157 | neural tube formation (GO:0001841) | 2.35241226 |
| 158 | regulation of translation in response to stress (GO:0043555) | 2.34856640 |
| 159 | histone lysine methylation (GO:0034968) | 2.32402484 |
| 160 | mRNA splice site selection (GO:0006376) | 2.32019719 |
| 161 | regulation of histone methylation (GO:0031060) | 2.31428381 |
| 162 | negative regulation of osteoblast proliferation (GO:0033689) | 2.30977552 |
| 163 | positive regulation of protein oligomerization (GO:0032461) | 2.30938676 |
| 164 | histone lysine demethylation (GO:0070076) | 2.30539618 |
| 165 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.28826635 |
| 166 | negative regulation of DNA repair (GO:0045738) | 2.28187498 |
| 167 | negative regulation of mRNA metabolic process (GO:1903312) | 2.26883354 |
| 168 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.25875892 |
| 169 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.25875892 |
| 170 | T cell differentiation involved in immune response (GO:0002292) | 2.25875892 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.17850498 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 5.43759650 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.50107144 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.39130027 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.37858608 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.10865732 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.10401086 |
| 8 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.34671740 |
| 9 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.28948043 |
| 10 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.23553167 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.14930075 |
| 12 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.80831979 |
| 13 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.70854450 |
| 14 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.60761189 |
| 15 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.58070300 |
| 16 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.56432402 |
| 17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.55774079 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54333500 |
| 19 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.32954223 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.31745037 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.31009078 |
| 22 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.28308779 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.19464324 |
| 24 | E2F7_22180533_ChIP-Seq_HELA_Human | 2.17783353 |
| 25 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.17352899 |
| 26 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.15173191 |
| 27 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.13796498 |
| 28 | * MYB_26560356_Chip-Seq_TH2_Human | 2.07513397 |
| 29 | GATA1_22025678_ChIP-Seq_K562_Human | 2.05823180 |
| 30 | * MYB_26560356_Chip-Seq_TH1_Human | 1.85182341 |
| 31 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.81609958 |
| 32 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.78741544 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.76899259 |
| 34 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.75915533 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.72349845 |
| 36 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.69649446 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69401559 |
| 38 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.64966891 |
| 39 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.64023240 |
| 40 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.62251143 |
| 41 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.61410524 |
| 42 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.60979608 |
| 43 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.58996289 |
| 44 | * PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.58032304 |
| 45 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.57405584 |
| 46 | MYC_22102868_ChIP-Seq_BL_Human | 1.55468281 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.53095215 |
| 48 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51758425 |
| 49 | * MAF_26560356_Chip-Seq_TH1_Human | 1.49005619 |
| 50 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.48706460 |
| 51 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47955097 |
| 52 | EWS_26573619_Chip-Seq_HEK293_Human | 1.47319785 |
| 53 | SPI1_23127762_ChIP-Seq_K562_Human | 1.44613093 |
| 54 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.44380299 |
| 55 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43543273 |
| 56 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.42431694 |
| 57 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.37356039 |
| 58 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.37228899 |
| 59 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.34257030 |
| 60 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.31617350 |
| 61 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.31010651 |
| 62 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29937345 |
| 63 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.29675950 |
| 64 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.27775741 |
| 65 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.26015110 |
| 66 | FUS_26573619_Chip-Seq_HEK293_Human | 1.25932922 |
| 67 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25558070 |
| 68 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.24522498 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.20633743 |
| 70 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.20161811 |
| 71 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.19920510 |
| 72 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.19473394 |
| 73 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.18865002 |
| 74 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.18735342 |
| 75 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.14037393 |
| 76 | * YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13461681 |
| 77 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.11181787 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.10635103 |
| 79 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.09949203 |
| 80 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08927283 |
| 81 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08680178 |
| 82 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.08525186 |
| 83 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.06176069 |
| 84 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.05493039 |
| 85 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.02536164 |
| 86 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01939354 |
| 87 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.01494671 |
| 88 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01269272 |
| 89 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.01023175 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.00875333 |
| 91 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.00354034 |
| 92 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00263038 |
| 93 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.99916048 |
| 94 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99403424 |
| 95 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 0.98841129 |
| 96 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.98021172 |
| 97 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97839998 |
| 98 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97675859 |
| 99 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97092466 |
| 100 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.97022259 |
| 101 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.96823139 |
| 102 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.96811160 |
| 103 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.95668979 |
| 104 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.95046554 |
| 105 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.94202958 |
| 106 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.94202958 |
| 107 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93948688 |
| 108 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 0.93896043 |
| 109 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.93831895 |
| 110 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.93515657 |
| 111 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 0.92659250 |
| 112 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.92445792 |
| 113 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.91800676 |
| 114 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91793573 |
| 115 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.90879068 |
| 116 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90129546 |
| 117 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89873401 |
| 118 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.89870100 |
| 119 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89790631 |
| 120 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89666784 |
| 121 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.89327880 |
| 122 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.89104051 |
| 123 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 0.88446484 |
| 124 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.88446194 |
| 125 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.86741237 |
| 126 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.85582224 |
| 127 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.82353715 |
| 128 | GATA2_19941826_ChIP-Seq_K562_Human | 0.81373994 |
| 129 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.80293871 |
| 130 | * GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.80292522 |
| 131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.79987914 |
| 132 | CJUN_26792858_Chip-Seq_BT549_Human | 0.79946634 |
| 133 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.79898714 |
| 134 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.78984425 |
| 135 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76889846 |
| 136 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.76489206 |
| 137 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.76268414 |
| 138 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74950259 |
| 139 | GATA1_19941826_ChIP-Seq_K562_Human | 0.74602007 |
| 140 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.73500769 |
| 141 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.73261746 |
| 142 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.72585800 |
| 143 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.72527802 |
| 144 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.71940917 |
| 145 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.71783902 |
| 146 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.71331224 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.23867011 |
| 2 | MP0000569_abnormal_digit_pigmentation | 4.10086599 |
| 3 | MP0009785_altered_susceptibility_to | 3.04951039 |
| 4 | MP0000685_abnormal_immune_system | 3.03130722 |
| 5 | MP0005671_abnormal_response_to | 3.01469721 |
| 6 | MP0005387_immune_system_phenotype | 2.92293702 |
| 7 | MP0001790_abnormal_immune_system | 2.92293702 |
| 8 | MP0002166_altered_tumor_susceptibility | 2.70899842 |
| 9 | MP0001800_abnormal_humoral_immune | 2.70832962 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.68894676 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.64617990 |
| 12 | MP0002419_abnormal_innate_immunity | 2.63868679 |
| 13 | MP0003436_decreased_susceptibility_to | 2.62079957 |
| 14 | MP0002452_abnormal_antigen_presenting | 2.57309514 |
| 15 | MP0005025_abnormal_response_to | 2.54017610 |
| 16 | MP0003656_abnormal_erythrocyte_physiolo | 2.43601861 |
| 17 | MP0002723_abnormal_immune_serum | 2.42229093 |
| 18 | MP0002006_tumorigenesis | 2.41668843 |
| 19 | MP0003724_increased_susceptibility_to | 2.34045473 |
| 20 | MP0001819_abnormal_immune_cell | 2.28533356 |
| 21 | MP0002420_abnormal_adaptive_immunity | 2.26363584 |
| 22 | MP0005464_abnormal_platelet_physiology | 2.17708736 |
| 23 | MP0002396_abnormal_hematopoietic_system | 2.13262008 |
| 24 | MP0003183_abnormal_peptide_metabolism | 2.06331914 |
| 25 | MP0003300_gastrointestinal_ulcer | 2.03346709 |
| 26 | MP0003763_abnormal_thymus_physiology | 2.00220587 |
| 27 | MP0005174_abnormal_tail_pigmentation | 1.99104223 |
| 28 | MP0004947_skin_inflammation | 1.91329701 |
| 29 | MP0010094_abnormal_chromosome_stability | 1.84555857 |
| 30 | MP0010155_abnormal_intestine_physiology | 1.83798951 |
| 31 | MP0002398_abnormal_bone_marrow | 1.81048658 |
| 32 | MP0006082_CNS_inflammation | 1.80833958 |
| 33 | MP0001853_heart_inflammation | 1.80744019 |
| 34 | MP0000372_irregular_coat_pigmentation | 1.76760132 |
| 35 | MP0003195_calcinosis | 1.74430326 |
| 36 | MP0003950_abnormal_plasma_membrane | 1.73632320 |
| 37 | MP0000716_abnormal_immune_system | 1.73138273 |
| 38 | MP0001873_stomach_inflammation | 1.69486570 |
| 39 | MP0002405_respiratory_system_inflammati | 1.68278057 |
| 40 | MP0003303_peritoneal_inflammation | 1.68273330 |
| 41 | MP0008877_abnormal_DNA_methylation | 1.62643009 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.61865515 |
| 43 | MP0003172_abnormal_lysosome_physiology | 1.61703225 |
| 44 | MP0004808_abnormal_hematopoietic_stem | 1.58326069 |
| 45 | MP0004510_myositis | 1.56772362 |
| 46 | MP0001533_abnormal_skeleton_physiology | 1.53779850 |
| 47 | MP0002009_preneoplasia | 1.53048111 |
| 48 | MP0009278_abnormal_bone_marrow | 1.52954998 |
| 49 | MP0010307_abnormal_tumor_latency | 1.52497918 |
| 50 | MP0005397_hematopoietic_system_phenotyp | 1.51415367 |
| 51 | MP0001545_abnormal_hematopoietic_system | 1.51415367 |
| 52 | MP0002163_abnormal_gland_morphology | 1.48972289 |
| 53 | MP0005310_abnormal_salivary_gland | 1.44579310 |
| 54 | MP0009764_decreased_sensitivity_to | 1.40081808 |
| 55 | MP0002429_abnormal_blood_cell | 1.39285405 |
| 56 | MP0008007_abnormal_cellular_replicative | 1.39215624 |
| 57 | MP0000689_abnormal_spleen_morphology | 1.37491892 |
| 58 | MP0002722_abnormal_immune_system | 1.34929912 |
| 59 | MP0008961_abnormal_basal_metabolism | 1.33142450 |
| 60 | MP0000015_abnormal_ear_pigmentation | 1.31902760 |
| 61 | MP0002998_abnormal_bone_remodeling | 1.30526489 |
| 62 | MP0005058_abnormal_lysosome_morphology | 1.26319783 |
| 63 | MP0003111_abnormal_nucleus_morphology | 1.24778033 |
| 64 | MP0003077_abnormal_cell_cycle | 1.22987670 |
| 65 | MP0002933_joint_inflammation | 1.21739793 |
| 66 | MP0008469_abnormal_protein_level | 1.20855864 |
| 67 | MP0002877_abnormal_melanocyte_morpholog | 1.20314032 |
| 68 | MP0008057_abnormal_DNA_replication | 1.20225020 |
| 69 | MP0003448_altered_tumor_morphology | 1.19620331 |
| 70 | MP0003252_abnormal_bile_duct | 1.19200861 |
| 71 | MP0000371_diluted_coat_color | 1.19165654 |
| 72 | MP0003786_premature_aging | 1.17969048 |
| 73 | MP0000703_abnormal_thymus_morphology | 1.13146981 |
| 74 | MP0002138_abnormal_hepatobiliary_system | 1.12488684 |
| 75 | MP0000383_abnormal_hair_follicle | 1.12120028 |
| 76 | MP0003866_abnormal_defecation | 1.11294807 |
| 77 | MP0003045_fibrosis | 1.06994161 |
| 78 | MP0000465_gastrointestinal_hemorrhage | 1.06511754 |
| 79 | MP0002019_abnormal_tumor_incidence | 1.06079896 |
| 80 | MP0008058_abnormal_DNA_repair | 1.05770394 |
| 81 | MP0000858_altered_metastatic_potential | 1.04927379 |
| 82 | MP0001879_abnormal_lymphatic_vessel | 1.03665627 |
| 83 | MP0009333_abnormal_splenocyte_physiolog | 1.03498001 |
| 84 | MP0005379_endocrine/exocrine_gland_phen | 1.01994216 |
| 85 | MP0002928_abnormal_bile_duct | 1.01449501 |
| 86 | MP0005621_abnormal_cell_physiology | 1.00942295 |
| 87 | MP0003221_abnormal_cardiomyocyte_apopto | 0.99986367 |
| 88 | MP0005075_abnormal_melanosome_morpholog | 0.94775315 |
| 89 | MP0006054_spinal_hemorrhage | 0.93510099 |
| 90 | MP0000350_abnormal_cell_proliferation | 0.93131331 |
| 91 | MP0002095_abnormal_skin_pigmentation | 0.92263351 |
| 92 | MP0000490_abnormal_crypts_of | 0.90032026 |
| 93 | MP0005451_abnormal_body_composition | 0.88572166 |
| 94 | MP0005220_abnormal_exocrine_pancreas | 0.86751588 |
| 95 | MP0008438_abnormal_cutaneous_collagen | 0.86380062 |
| 96 | MP0000767_abnormal_smooth_muscle | 0.85711416 |
| 97 | MP0002254_reproductive_system_inflammat | 0.84789430 |
| 98 | MP0000013_abnormal_adipose_tissue | 0.83712561 |
| 99 | MP0010352_gastrointestinal_tract_polyps | 0.82888082 |
| 100 | MP0003566_abnormal_cell_adhesion | 0.81977376 |
| 101 | MP0003091_abnormal_cell_migration | 0.81737219 |
| 102 | MP0009763_increased_sensitivity_to | 0.81693546 |
| 103 | MP0004381_abnormal_hair_follicle | 0.80659430 |
| 104 | MP0008995_early_reproductive_senescence | 0.80415158 |
| 105 | MP0001851_eye_inflammation | 0.79940992 |
| 106 | MP0005390_skeleton_phenotype | 0.79457283 |
| 107 | MP0002168_other_aberrant_phenotype | 0.79265678 |
| 108 | MP0002693_abnormal_pancreas_physiology | 0.77542588 |
| 109 | MP0005384_cellular_phenotype | 0.77254772 |
| 110 | MP0008260_abnormal_autophagy | 0.76218993 |
| 111 | MP0005645_abnormal_hypothalamus_physiol | 0.75470677 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.74276793 |
| 113 | MP0003795_abnormal_bone_structure | 0.73814016 |
| 114 | MP0001191_abnormal_skin_condition | 0.73712752 |
| 115 | MP0004134_abnormal_chest_morphology | 0.72345834 |
| 116 | MP0010678_abnormal_skin_adnexa | 0.71214139 |
| 117 | MP0003828_pulmonary_edema | 0.70185683 |
| 118 | MP0000003_abnormal_adipose_tissue | 0.69795032 |
| 119 | MP0001348_abnormal_lacrimal_gland | 0.66588889 |
| 120 | MP0000343_altered_response_to | 0.65095834 |
| 121 | MP0000598_abnormal_liver_morphology | 0.65011914 |
| 122 | MP0005408_hypopigmentation | 0.64802239 |
| 123 | MP0003279_aneurysm | 0.64629981 |
| 124 | MP0009765_abnormal_xenobiotic_induced | 0.64160674 |
| 125 | MP0005076_abnormal_cell_differentiation | 0.63654975 |
| 126 | MP0002132_abnormal_respiratory_system | 0.63483977 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.63426004 |
| 128 | MP0000313_abnormal_cell_death | 0.63396872 |
| 129 | MP0001958_emphysema | 0.63192808 |
| 130 | MP0002277_abnormal_respiratory_mucosa | 0.63014590 |
| 131 | MP0000249_abnormal_blood_vessel | 0.62189557 |
| 132 | MP0002075_abnormal_coat/hair_pigmentati | 0.60525642 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.59713447 |
| 134 | MP0003943_abnormal_hepatobiliary_system | 0.58674510 |
| 135 | MP0001186_pigmentation_phenotype | 0.58571477 |
| 136 | MP0003453_abnormal_keratinocyte_physiol | 0.58410002 |
| 137 | MP0001915_intracranial_hemorrhage | 0.57151057 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.96418733 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 4.78133499 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.51535132 |
| 4 | Myositis (HP:0100614) | 3.96611299 |
| 5 | Recurrent fungal infections (HP:0002841) | 3.90248570 |
| 6 | Retrobulbar optic neuritis (HP:0100654) | 3.87418874 |
| 7 | Optic neuritis (HP:0100653) | 3.87418874 |
| 8 | Recurrent viral infections (HP:0004429) | 3.74435817 |
| 9 | Orchitis (HP:0100796) | 3.53138997 |
| 10 | Chronic otitis media (HP:0000389) | 3.40667316 |
| 11 | Recurrent skin infections (HP:0001581) | 3.35154142 |
| 12 | Mediastinal lymphadenopathy (HP:0100721) | 3.32428832 |
| 13 | Periodontitis (HP:0000704) | 3.29704693 |
| 14 | Abnormality of the fingertips (HP:0001211) | 3.28609363 |
| 15 | Recurrent cutaneous fungal infections (HP:0011370) | 3.26730823 |
| 16 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.26730823 |
| 17 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 3.22795139 |
| 18 | Vasculitis (HP:0002633) | 3.22151678 |
| 19 | Autoimmune thrombocytopenia (HP:0001973) | 3.21595962 |
| 20 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.09718387 |
| 21 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.08947486 |
| 22 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.07592984 |
| 23 | Pulmonary infiltrates (HP:0002113) | 3.02678471 |
| 24 | Meningitis (HP:0001287) | 2.93646157 |
| 25 | Combined immunodeficiency (HP:0005387) | 2.91970686 |
| 26 | Agammaglobulinemia (HP:0004432) | 2.91064128 |
| 27 | Eosinophilia (HP:0001880) | 2.90919669 |
| 28 | Gingivitis (HP:0000230) | 2.87066606 |
| 29 | Abnormality of macrophages (HP:0004311) | 2.86162814 |
| 30 | Volvulus (HP:0002580) | 2.82890200 |
| 31 | Fatigue (HP:0012378) | 2.81882441 |
| 32 | Chronic diarrhea (HP:0002028) | 2.81531937 |
| 33 | Cutaneous melanoma (HP:0012056) | 2.79646877 |
| 34 | Abnormality of T cell number (HP:0011839) | 2.74362673 |
| 35 | Pustule (HP:0200039) | 2.66106505 |
| 36 | Panhypogammaglobulinemia (HP:0003139) | 2.64956592 |
| 37 | T lymphocytopenia (HP:0005403) | 2.64733323 |
| 38 | Hemoptysis (HP:0002105) | 2.64245557 |
| 39 | Arterial thrombosis (HP:0004420) | 2.63959071 |
| 40 | Hematochezia (HP:0002573) | 2.62840198 |
| 41 | Stomatitis (HP:0010280) | 2.59447879 |
| 42 | Leukocytosis (HP:0001974) | 2.57421560 |
| 43 | Prostate neoplasm (HP:0100787) | 2.56367946 |
| 44 | Papillary thyroid carcinoma (HP:0002895) | 2.55827732 |
| 45 | Thyroiditis (HP:0100646) | 2.55809167 |
| 46 | Recurrent bronchitis (HP:0002837) | 2.54371278 |
| 47 | Granulocytopenia (HP:0001913) | 2.53647992 |
| 48 | Thick nail (HP:0001805) | 2.50162774 |
| 49 | Cellulitis (HP:0100658) | 2.49651626 |
| 50 | B lymphocytopenia (HP:0010976) | 2.48692602 |
| 51 | Abnormality of B cell number (HP:0010975) | 2.48692602 |
| 52 | Colitis (HP:0002583) | 2.47988384 |
| 53 | Keratoconjunctivitis sicca (HP:0001097) | 2.46064453 |
| 54 | Osteomyelitis (HP:0002754) | 2.46064171 |
| 55 | Deep philtrum (HP:0002002) | 2.45609475 |
| 56 | Abnormality of eosinophils (HP:0001879) | 2.44534773 |
| 57 | Recurrent pneumonia (HP:0006532) | 2.38509689 |
| 58 | Gingival bleeding (HP:0000225) | 2.36477288 |
| 59 | Overlapping toe (HP:0001845) | 2.36123349 |
| 60 | Inflammation of the large intestine (HP:0002037) | 2.34839326 |
| 61 | Acute hepatic failure (HP:0006554) | 2.33668936 |
| 62 | Thyroid carcinoma (HP:0002890) | 2.33333315 |
| 63 | Submucous cleft hard palate (HP:0000176) | 2.31620366 |
| 64 | Heterotopia (HP:0002282) | 2.30850895 |
| 65 | Lymphopenia (HP:0001888) | 2.30850624 |
| 66 | Prolonged bleeding time (HP:0003010) | 2.28963199 |
| 67 | Keratoconjunctivitis (HP:0001096) | 2.28759904 |
| 68 | Abnormality of T cells (HP:0002843) | 2.28143634 |
| 69 | IgA deficiency (HP:0002720) | 2.25952269 |
| 70 | Chronic obstructive pulmonary disease (HP:0006510) | 2.25924153 |
| 71 | Obstructive lung disease (HP:0006536) | 2.25924153 |
| 72 | Vacuolated lymphocytes (HP:0001922) | 2.24865228 |
| 73 | Basal cell carcinoma (HP:0002671) | 2.22289169 |
| 74 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.21377869 |
| 75 | Spontaneous hematomas (HP:0007420) | 2.17338887 |
| 76 | Thickened calvaria (HP:0002684) | 2.17322531 |
| 77 | Basal ganglia calcification (HP:0002135) | 2.17186707 |
| 78 | Acute myeloid leukemia (HP:0004808) | 2.16256449 |
| 79 | Increased IgM level (HP:0003496) | 2.15129514 |
| 80 | Myelodysplasia (HP:0002863) | 2.13431004 |
| 81 | Acute lymphatic leukemia (HP:0006721) | 2.12614588 |
| 82 | Premature loss of primary teeth (HP:0006323) | 2.12080353 |
| 83 | Increased IgE level (HP:0003212) | 2.11939477 |
| 84 | Abnormality of T cell physiology (HP:0011840) | 2.11815002 |
| 85 | Gastrointestinal inflammation (HP:0004386) | 2.11626084 |
| 86 | Cheilitis (HP:0100825) | 2.11119766 |
| 87 | Gastrointestinal stroma tumor (HP:0100723) | 2.10539054 |
| 88 | Autoimmune hemolytic anemia (HP:0001890) | 2.09822057 |
| 89 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09761957 |
| 90 | Spondylolisthesis (HP:0003302) | 2.09132101 |
| 91 | Epistaxis (HP:0000421) | 2.08335850 |
| 92 | Viral hepatitis (HP:0006562) | 2.07263680 |
| 93 | Encephalitis (HP:0002383) | 2.06800905 |
| 94 | Absent frontal sinuses (HP:0002688) | 2.06533692 |
| 95 | Stomach cancer (HP:0012126) | 2.06082332 |
| 96 | IgM deficiency (HP:0002850) | 2.04056810 |
| 97 | Recurrent lower respiratory tract infections (HP:0002783) | 2.02566651 |
| 98 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.02043836 |
| 99 | Abnormality of the prostate (HP:0008775) | 2.01336690 |
| 100 | Hypoplasia of the thymus (HP:0000778) | 2.01317349 |
| 101 | Abnormality of the common coagulation pathway (HP:0010990) | 2.01253948 |
| 102 | Cystic hygroma (HP:0000476) | 2.01122147 |
| 103 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.00845622 |
| 104 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.00845622 |
| 105 | Thrombocytosis (HP:0001894) | 2.00535177 |
| 106 | IgG deficiency (HP:0004315) | 1.98996274 |
| 107 | Hypergammaglobulinemia (HP:0010702) | 1.96023161 |
| 108 | Curly hair (HP:0002212) | 1.95648019 |
| 109 | Interstitial pulmonary disease (HP:0006530) | 1.95480557 |
| 110 | Keratitis (HP:0000491) | 1.95352927 |
| 111 | Abnormality of the peritoneum (HP:0002585) | 1.93014252 |
| 112 | Severe combined immunodeficiency (HP:0004430) | 1.92793071 |
| 113 | Degeneration of anterior horn cells (HP:0002398) | 1.92631180 |
| 114 | Abnormality of the anterior horn cell (HP:0006802) | 1.92631180 |
| 115 | Nephroblastoma (Wilms tumor) (HP:0002667) | 1.92497193 |
| 116 | Albinism (HP:0001022) | 1.91739600 |
| 117 | Emphysema (HP:0002097) | 1.89982043 |
| 118 | Spinal cord lesions (HP:0100561) | 1.89486462 |
| 119 | Syringomyelia (HP:0003396) | 1.89486462 |
| 120 | Somatic mutation (HP:0001428) | 1.89139993 |
| 121 | Papilloma (HP:0012740) | 1.88263509 |
| 122 | Verrucae (HP:0200043) | 1.88263509 |
| 123 | Chronic sinusitis (HP:0011109) | 1.88038010 |
| 124 | Increased cerebral lipofuscin (HP:0011813) | 1.86359806 |
| 125 | Lymphoma (HP:0002665) | 1.86170469 |
| 126 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.86146789 |
| 127 | Chest pain (HP:0100749) | 1.85291302 |
| 128 | Large for gestational age (HP:0001520) | 1.85237042 |
| 129 | Skin ulcer (HP:0200042) | 1.83070821 |
| 130 | Prominent metopic ridge (HP:0005487) | 1.82676843 |
| 131 | Embryonal renal neoplasm (HP:0011794) | 1.81822653 |
| 132 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.80207906 |
| 133 | Lip pit (HP:0100267) | 1.80071278 |
| 134 | Broad alveolar ridges (HP:0000187) | 1.79956462 |
| 135 | Sepsis (HP:0100806) | 1.79121744 |
| 136 | Prominent nose (HP:0000448) | 1.78299988 |
| 137 | Alveolar cell carcinoma (HP:0006519) | 1.77153985 |
| 138 | Gastrointestinal infarctions (HP:0005244) | 1.77021235 |
| 139 | Abnormality of the frontal sinuses (HP:0002687) | 1.76886754 |
| 140 | Low anterior hairline (HP:0000294) | 1.76823985 |
| 141 | Recurrent sinusitis (HP:0011108) | 1.76603435 |
| 142 | Asymmetry of the thorax (HP:0001555) | 1.75996540 |
| 143 | Microvesicular hepatic steatosis (HP:0001414) | 1.75099628 |
| 144 | White forelock (HP:0002211) | 1.74459470 |
| 145 | Chromsome breakage (HP:0040012) | 1.74127149 |
| 146 | Joint swelling (HP:0001386) | 1.72560328 |
| 147 | Ascites (HP:0001541) | 1.72157450 |
| 148 | Bladder neoplasm (HP:0009725) | 1.70144136 |
| 149 | Bladder carcinoma (HP:0002862) | 1.70144136 |
| 150 | Abnormality of the metopic suture (HP:0005556) | 1.69008191 |
| 151 | Aortic aneurysm (HP:0004942) | 1.67454053 |
| 152 | Truncal obesity (HP:0001956) | 1.66651164 |
| 153 | Broad palm (HP:0001169) | 1.64371958 |
| 154 | Ureteral obstruction (HP:0006000) | 1.63522081 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EIF2AK3 | 4.28280179 |
| 2 | MAP3K14 | 3.94278707 |
| 3 | IRAK3 | 3.32391575 |
| 4 | AKT3 | 2.98930780 |
| 5 | IRAK4 | 2.96454691 |
| 6 | JAK3 | 2.95747174 |
| 7 | TXK | 2.87180296 |
| 8 | MAP4K1 | 2.81306712 |
| 9 | TYK2 | 2.75989822 |
| 10 | IKBKE | 2.67434037 |
| 11 | KIT | 2.48506944 |
| 12 | JAK1 | 2.43277890 |
| 13 | TBK1 | 2.40204351 |
| 14 | BRSK2 | 2.37133291 |
| 15 | MAP3K13 | 2.26296113 |
| 16 | TAOK3 | 2.18612291 |
| 17 | BCKDK | 2.10330652 |
| 18 | RIPK4 | 2.09125700 |
| 19 | PASK | 2.00058477 |
| 20 | IKBKB | 1.99765220 |
| 21 | TEC | 1.86594629 |
| 22 | BLK | 1.84259145 |
| 23 | CHUK | 1.63909579 |
| 24 | EIF2AK1 | 1.62359713 |
| 25 | INSRR | 1.62017825 |
| 26 | TGFBR2 | 1.60674919 |
| 27 | FGFR4 | 1.55853465 |
| 28 | CAMKK2 | 1.53682301 |
| 29 | MKNK1 | 1.48435573 |
| 30 | BTK | 1.47497303 |
| 31 | SIK3 | 1.43724617 |
| 32 | ZAP70 | 1.42761475 |
| 33 | MKNK2 | 1.39805056 |
| 34 | FGFR3 | 1.34298711 |
| 35 | SIK2 | 1.34055444 |
| 36 | ITK | 1.33884996 |
| 37 | SYK | 1.32788824 |
| 38 | PAK3 | 1.31399565 |
| 39 | MELK | 1.30357525 |
| 40 | LCK | 1.28744469 |
| 41 | TRIM28 | 1.26609598 |
| 42 | CSF1R | 1.26271929 |
| 43 | ERN1 | 1.24714594 |
| 44 | PRPF4B | 1.24084911 |
| 45 | EPHB1 | 1.23966741 |
| 46 | NLK | 1.21842208 |
| 47 | NUAK1 | 1.21461642 |
| 48 | MARK3 | 1.21312444 |
| 49 | EPHA3 | 1.21052293 |
| 50 | IRAK1 | 1.20391686 |
| 51 | BCR | 1.18028934 |
| 52 | CSK | 1.14674480 |
| 53 | HCK | 1.14199835 |
| 54 | BRD4 | 1.12617871 |
| 55 | SIK1 | 1.06574356 |
| 56 | TRPM7 | 1.02324694 |
| 57 | LYN | 1.01591641 |
| 58 | CAMK1D | 0.99517374 |
| 59 | PKN2 | 0.98092769 |
| 60 | FLT3 | 0.97623112 |
| 61 | STK10 | 0.96699536 |
| 62 | YES1 | 0.96230863 |
| 63 | EIF2AK2 | 0.94651181 |
| 64 | PTK6 | 0.89809176 |
| 65 | FRK | 0.87267251 |
| 66 | NEK9 | 0.86939416 |
| 67 | CDK12 | 0.86879075 |
| 68 | JAK2 | 0.86495499 |
| 69 | PIM1 | 0.84931622 |
| 70 | CAMK1G | 0.84665431 |
| 71 | WNK1 | 0.83589794 |
| 72 | MST4 | 0.81812161 |
| 73 | HIPK2 | 0.77326885 |
| 74 | RIPK1 | 0.77184392 |
| 75 | FES | 0.75548574 |
| 76 | PIK3CG | 0.75270095 |
| 77 | NEK1 | 0.70256932 |
| 78 | RPS6KA4 | 0.69833490 |
| 79 | PRKCQ | 0.69753634 |
| 80 | PIK3CA | 0.69505394 |
| 81 | STK24 | 0.68770290 |
| 82 | ZAK | 0.67867486 |
| 83 | BUB1 | 0.65612872 |
| 84 | FGR | 0.64939332 |
| 85 | PRKAA2 | 0.64339766 |
| 86 | ATM | 0.63442544 |
| 87 | TIE1 | 0.61523389 |
| 88 | CHEK1 | 0.60958040 |
| 89 | STK3 | 0.60663018 |
| 90 | TNIK | 0.60378795 |
| 91 | IRAK2 | 0.59861700 |
| 92 | CLK1 | 0.59680996 |
| 93 | MAP3K5 | 0.59477587 |
| 94 | MAP2K3 | 0.58330337 |
| 95 | CDK6 | 0.57798276 |
| 96 | PDGFRB | 0.57529802 |
| 97 | ABL1 | 0.56211911 |
| 98 | MAP3K10 | 0.56200112 |
| 99 | BMPR2 | 0.55633735 |
| 100 | TTN | 0.54726232 |
| 101 | CDK4 | 0.54255560 |
| 102 | ERBB3 | 0.53773003 |
| 103 | STK4 | 0.53093694 |
| 104 | MAPK15 | 0.52827966 |
| 105 | MAP3K4 | 0.48851878 |
| 106 | IGF1R | 0.48262384 |
| 107 | MAPK7 | 0.47511051 |
| 108 | LATS1 | 0.47313615 |
| 109 | CDK8 | 0.47072305 |
| 110 | FGFR2 | 0.45867570 |
| 111 | RPS6KB2 | 0.45189307 |
| 112 | MAP3K7 | 0.44047515 |
| 113 | MUSK | 0.41357776 |
| 114 | RAF1 | 0.41184493 |
| 115 | CDK9 | 0.41111917 |
| 116 | ATR | 0.40927903 |
| 117 | RET | 0.40751919 |
| 118 | MATK | 0.39406017 |
| 119 | SGK2 | 0.38203334 |
| 120 | PRKCH | 0.38076010 |
| 121 | PLK3 | 0.37404128 |
| 122 | FGFR1 | 0.37356678 |
| 123 | BRSK1 | 0.36968845 |
| 124 | PDGFRA | 0.36166456 |
| 125 | CDC42BPA | 0.35981105 |
| 126 | SGK3 | 0.34862463 |
| 127 | GRK1 | 0.34672303 |
| 128 | BMPR1B | 0.29531201 |
| 129 | SGK1 | 0.29459678 |
| 130 | MAPK3 | 0.28839769 |
| 131 | MAPKAPK2 | 0.28817958 |
| 132 | EGFR | 0.27873501 |
| 133 | PRKCD | 0.27815202 |
| 134 | MAPK11 | 0.27007577 |
| 135 | RPS6KA6 | 0.26455426 |
| 136 | KDR | 0.24985857 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.87803318 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.65241470 |
| 3 | Leishmaniasis_Homo sapiens_hsa05140 | 2.54601560 |
| 4 | Measles_Homo sapiens_hsa05162 | 2.50692590 |
| 5 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.38875894 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29885092 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28491522 |
| 8 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.24447634 |
| 9 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17254633 |
| 10 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.15833390 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.11718087 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.10684704 |
| 13 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.04852650 |
| 14 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01883752 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.93579022 |
| 16 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.82588305 |
| 17 | Influenza A_Homo sapiens_hsa05164 | 1.79719139 |
| 18 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.76546476 |
| 19 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.72442993 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.70195226 |
| 21 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.57956628 |
| 22 | Legionellosis_Homo sapiens_hsa05134 | 1.57586950 |
| 23 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.57291423 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.56370018 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.56291405 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.54263326 |
| 27 | Circadian rhythm_Homo sapiens_hsa04710 | 1.47493332 |
| 28 | Tuberculosis_Homo sapiens_hsa05152 | 1.43383067 |
| 29 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.42860088 |
| 30 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.39711011 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.39399307 |
| 32 | Pertussis_Homo sapiens_hsa05133 | 1.36874176 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.36479149 |
| 34 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.28382191 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.24846116 |
| 36 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24172796 |
| 37 | RNA degradation_Homo sapiens_hsa03018 | 1.22081207 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21041444 |
| 39 | Asthma_Homo sapiens_hsa05310 | 1.20819741 |
| 40 | Apoptosis_Homo sapiens_hsa04210 | 1.20609640 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 1.19683140 |
| 42 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.19390689 |
| 43 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 1.18440534 |
| 44 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.14954043 |
| 45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.12367399 |
| 46 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.12328639 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09783487 |
| 48 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.09579886 |
| 49 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.07350020 |
| 50 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.07225258 |
| 51 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.07187038 |
| 52 | Other glycan degradation_Homo sapiens_hsa00511 | 1.06998607 |
| 53 | Colorectal cancer_Homo sapiens_hsa05210 | 1.05305278 |
| 54 | Cell cycle_Homo sapiens_hsa04110 | 1.04852099 |
| 55 | Endometrial cancer_Homo sapiens_hsa05213 | 1.04549181 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.03308389 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02900751 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.98430953 |
| 59 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.95208704 |
| 60 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94551590 |
| 61 | Spliceosome_Homo sapiens_hsa03040 | 0.93724491 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.93257787 |
| 63 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.92588105 |
| 64 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.92275675 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.91234867 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.87874863 |
| 67 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.85107000 |
| 68 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85028094 |
| 69 | Platelet activation_Homo sapiens_hsa04611 | 0.84438138 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.83679413 |
| 71 | ABC transporters_Homo sapiens_hsa02010 | 0.83106477 |
| 72 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.82768978 |
| 73 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.82251180 |
| 74 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.82247765 |
| 75 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.80795106 |
| 76 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79393245 |
| 77 | Salmonella infection_Homo sapiens_hsa05132 | 0.78831570 |
| 78 | Shigellosis_Homo sapiens_hsa05131 | 0.78613202 |
| 79 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.78143304 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.75635384 |
| 81 | Phagosome_Homo sapiens_hsa04145 | 0.73328857 |
| 82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.72836684 |
| 83 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.72791723 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.68552307 |
| 85 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.67359769 |
| 86 | Protein export_Homo sapiens_hsa03060 | 0.62903718 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61724734 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.61490035 |
| 89 | HTLV-I infection_Homo sapiens_hsa05166 | 0.61016612 |
| 90 | Prostate cancer_Homo sapiens_hsa05215 | 0.60630516 |
| 91 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.59110672 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57504412 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.57444211 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.57358865 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56681965 |
| 96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.56147549 |
| 97 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55609200 |
| 98 | Melanoma_Homo sapiens_hsa05218 | 0.55406474 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.55269529 |
| 100 | Lysine degradation_Homo sapiens_hsa00310 | 0.55202436 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.54408755 |
| 102 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.53603678 |
| 103 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.52835116 |
| 104 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.52033399 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51969063 |
| 106 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.50954139 |
| 107 | RNA transport_Homo sapiens_hsa03013 | 0.50666854 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50381529 |
| 109 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.48851901 |
| 110 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48678438 |
| 111 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.47475861 |
| 112 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.47196787 |
| 113 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.47065955 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45415649 |
| 115 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44035249 |
| 116 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.43596314 |
| 117 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43010275 |
| 118 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42835688 |
| 119 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.42825943 |
| 120 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.42757024 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.42734183 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.41210077 |
| 123 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41006244 |
| 124 | Adherens junction_Homo sapiens_hsa04520 | 0.36795023 |
| 125 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.36657492 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.33685992 |
| 127 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.32104854 |
| 128 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.30690272 |

